|
2026-05-21 |
2026-05-21 |
S
Sale
|
Non-Executive Director
|
1,066
-0.9%
111.48
US$4,449,627
|
1,066
-0.9%
|
111.48
|
US$4,449,627
|
|
|
2026-05-21 |
2026-05-21 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
5,948
364.47
US$3,840,158
|
5,948
|
364.47
|
US$3,840,158
|
|
|
2026-05-22 |
2026-05-20 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
17,807
226.34
US$2,563,690
|
17,807
|
226.34
|
US$2,563,690
|
|
|
2026-05-22 |
2026-05-20 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
2,263
94.69
US$214,283
|
2,263
|
94.69
|
US$214,283
|
|
|
2026-05-21 |
2026-05-20 |
S
Sale
|
Non-Executive Director
|
800
-0.0%
96.28
US$77,026
|
800
-0.0%
|
96.28
|
US$77,026
|
|
|
2026-05-21 |
2026-05-20 |
S
Sale
|
Non-Executive Director
|
66,881
-1.3%
95.67
US$6,398,204
|
66,881
-1.3%
|
95.67
|
US$6,398,204
|
|
|
2026-05-21 |
2026-05-20 |
S
Sale
|
Non-Executive Director
|
152,691
-2.8%
94.81
US$14,476,038
|
152,691
-2.8%
|
94.81
|
US$14,476,038
|
|
|
2026-05-21 |
2026-05-20 |
S
Sale
|
Non-Executive Director
|
797,628
-12.8%
93.48
US$74,559,554
|
797,628
-12.8%
|
93.48
|
US$74,559,554
|
|
|
2026-05-21 |
2026-05-19 |
S
Sale
|
Non-Executive Director
|
151
-0.0%
95.18
US$14,372
|
151
-0.0%
|
95.18
|
US$14,372
|
|
|
2026-05-21 |
2026-05-19 |
S
Sale
|
Non-Executive Director
|
1,983,387
-24.2%
94.45
US$187,326,935
|
1,983,387
-24.2%
|
94.45
|
US$187,326,935
|
|
|
2026-05-11 |
2026-05-08 |
S
Sale
|
EVP, Chief Exp & Tech Officer
Officer
|
69,551
-87.3%
89.58
US$6,230,379
|
69,551
-87.3%
|
89.58
|
US$6,230,379
|
|
|
2026-05-08 |
2026-05-08 |
PrS
Proposed sale
|
Officer
Officer
|
69,551
89.58
US$6,230,719
|
69,551
|
89.58
|
US$6,230,719
|
|
|
2025-08-29 |
2025-08-20 |
S
Sale
|
Non-Executive Director
|
7,500
-25.3%
71.02
US$532,650
|
7,500
-25.3%
|
71.02
|
US$532,650
|
|
|
2025-08-19 |
2025-08-20 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
7,500
70.97
US$532,275
|
7,500
|
70.97
|
US$532,275
|
|
|
2025-06-09 |
2025-06-05 |
B
Purchase
|
Non-Executive Director
|
1,570
+15.0%
63.70
US$100,009
|
1,570
+15.0%
|
63.70
|
US$100,009
|
|
|
2025-05-06 |
2025-05-06 |
S
Sale
|
Non-Executive Director
|
150,000
-1.8%
66.67
US$10,000,710
|
150,000
-1.8%
|
66.67
|
US$10,000,710
|
|
|
2025-05-06 |
2025-05-05 |
S
Sale
|
Non-Executive Director
|
96,999
-1.1%
67.99
US$6,595,272
|
96,999
-1.1%
|
67.99
|
US$6,595,272
|
|
|
2025-05-06 |
2025-05-05 |
S
Sale
|
Non-Executive Director
|
1,226,933
-12.7%
67.37
US$82,654,673
|
1,226,933
-12.7%
|
67.37
|
US$82,654,673
|
|
|
2025-05-06 |
2025-05-02 |
S
Sale
|
Non-Executive Director
|
373,776
-3.7%
69.66
US$26,035,592
|
373,776
-3.7%
|
69.66
|
US$26,035,592
|
|
|
2025-05-06 |
2025-05-02 |
S
Sale
|
Non-Executive Director
|
222,556
-2.2%
68.38
US$15,218,980
|
222,556
-2.2%
|
68.38
|
US$15,218,980
|
|
|
2025-05-06 |
2025-05-02 |
S
Sale
|
Non-Executive Director
|
1,679,736
-14.1%
67.39
US$113,190,186
|
1,679,736
-14.1%
|
67.39
|
US$113,190,186
|
|
|
2025-03-07 |
2025-03-05 |
S
Sale
|
SVP, Cont & Chief Acct Officer
Officer
|
7,513
-47.2%
66.35
US$498,488
|
7,513
-47.2%
|
66.35
|
US$498,488
|
|
|
2025-03-05 |
2025-03-05 |
PrS
Proposed sale
|
Officer
Officer
|
7,513
66.35
US$498,489
|
7,513
|
66.35
|
US$498,489
|
|
|
2025-02-19 |
2025-02-18 |
B
Purchase
|
Non-Executive Director
|
30,000
+320.6%
66.70
US$2,001,000
|
30,000
+320.6%
|
66.70
|
US$2,001,000
|
|
|
2026-01-27 |
2025-01-23 |
B
Purchase
|
EVP and President, Aetna
Officer
|
24
+inf%
53.70
US$1,289
|
24
+inf%
|
53.70
|
US$1,289
|
|
|
2025-10-14 |
2024-10-23 |
B
Purchase
|
EVP and Chief People Officer
Officer
|
35
+70.0%
56.85
US$1,990
|
35
+70.0%
|
56.85
|
US$1,990
|
|
|
2025-10-14 |
2024-10-02 |
B
Purchase
|
EVP and Chief People Officer
Officer
|
10
+25.0%
62.24
US$622
|
10
+25.0%
|
62.24
|
US$622
|
|
|
2025-10-14 |
2024-09-09 |
B
Purchase
|
EVP and Chief People Officer
Officer
|
35
+700.0%
56.47
US$1,976
|
35
+700.0%
|
56.47
|
US$1,976
|
|
|
2024-05-02 |
2024-05-02 |
B
Purchase
|
Non-Executive Director
|
1,000
+4.8%
53.88
US$53,879
|
1,000
+4.8%
|
53.88
|
US$53,879
|
|
|
2024-05-02 |
2024-05-02 |
B
Purchase
|
Non-Executive Director
|
9,181
+5246.3%
54.49
US$500,294
|
9,181
+5246.3%
|
54.49
|
US$500,294
|
|
|
2024-02-16 |
2024-02-16 |
PrS
Proposed sale
|
Officer
Officer
|
29,473
76.95
US$2,267,924
|
29,473
|
76.95
|
US$2,267,924
|
|
|
2024-02-16 |
2024-02-16 |
S
Sale
|
EVP and Pres-Pharm, Consumer W
Officer
|
29,473
-42.6%
76.95
US$2,267,947
|
29,473
-42.6%
|
76.95
|
US$2,267,947
|
|
|
2023-11-06 |
2023-11-03 |
B
Purchase
|
Non-Executive Director
|
2,000
+10.7%
70.47
US$140,930
|
2,000
+10.7%
|
70.47
|
US$140,930
|
|
|
2023-08-04 |
2023-08-03 |
S
Sale
|
SVP, Cont & Chief Acct Officer
Officer
|
23,128
-83.1%
74.94
US$1,733,212
|
23,128
-83.1%
|
74.94
|
US$1,733,212
|
|
|
2023-08-04 |
2023-08-03 |
S
Sale
|
SVP, Cont & Chief Acct Officer
Officer
|
2,631
-8.6%
74.79
US$196,792
|
2,631
-8.6%
|
74.79
|
US$196,792
|
|
|
2023-08-03 |
2023-08-03 |
PrS
Proposed sale
|
Officer
Officer
|
25,759
74.92
US$1,929,930
|
25,759
|
74.92
|
US$1,929,930
|
|
|
2023-05-05 |
2023-05-03 |
B
Purchase
|
President and CEO
Executive Director
|
14,000
+3.4%
69.75
US$976,567
|
14,000
+3.4%
|
69.75
|
US$976,567
|
|
|
2022-12-16 |
2022-12-15 |
PlS
Planned sale
|
EVP & General Counsel
Officer
|
36,490
-5.7%
98.24
US$3,584,869
|
36,490
-5.7%
|
98.24
|
US$3,584,869
|
|
|
2022-12-16 |
2022-12-15 |
PlS
Planned sale
|
EVP & General Counsel
Officer
|
100,976
-14.2%
98.40
US$9,936,311
|
100,976
-14.2%
|
98.40
|
US$9,936,311
|
|
|
2022-08-05 |
2022-08-04 |
PlS
Planned sale
|
EVP&President-PharmacyServices
Officer
|
22,541
-17.1%
104.00
US$2,344,264
|
22,541
-17.1%
|
104.00
|
US$2,344,264
|
|
|
2022-08-05 |
2022-08-03 |
PlS
Planned sale
|
EVP&President-PharmacyServices
Officer
|
50,501
-31.6%
98.00
US$4,949,098
|
50,501
-31.6%
|
98.00
|
US$4,949,098
|
|
|
2022-08-05 |
2022-08-03 |
PlS
Planned sale
|
EVP&President-PharmacyServices
Officer
|
70,398
-39.2%
98.00
US$6,899,004
|
70,398
-39.2%
|
98.00
|
US$6,899,004
|
|
|
2022-08-05 |
2022-08-03 |
PlS
Planned sale
|
EVP/Pres, Health Care Benefits
Officer
|
9,546
-22.9%
100.00
US$954,600
|
9,546
-22.9%
|
100.00
|
US$954,600
|
|
|
2022-04-12 |
2022-04-08 |
PlS
Planned sale
|
EVP and Co-President of Retail
Officer
|
3,130
-6.7%
105.00
US$328,650
|
3,130
-6.7%
|
105.00
|
US$328,650
|
|
|
2022-04-12 |
2022-04-08 |
PlS
Planned sale
|
EVP and Co-President of Retail
Officer
|
4,103
-8.1%
105.00
US$430,815
|
4,103
-8.1%
|
105.00
|
US$430,815
|
|
|
2022-04-12 |
2022-04-08 |
PlS
Planned sale
|
EVP and Co-President of Retail
Officer
|
5,719
-10.9%
105.00
US$600,495
|
5,719
-10.9%
|
105.00
|
US$600,495
|
|
|
2022-04-12 |
2022-04-08 |
PlS
Planned sale
|
EVP and Co-President of Retail
Officer
|
3,157
-6.3%
105.00
US$331,485
|
3,157
-6.3%
|
105.00
|
US$331,485
|
|
|
2022-04-12 |
2022-04-08 |
PlS
Planned sale
|
EVP and Co-President of Retail
Officer
|
845
-1.8%
105.00
US$88,725
|
845
-1.8%
|
105.00
|
US$88,725
|
|
|
2022-04-06 |
2022-04-05 |
PlS
Planned sale
|
EVP/Pres, Health Care Benefits
Officer
|
5,941
-15.6%
100.00
US$594,100
|
5,941
-15.6%
|
100.00
|
US$594,100
|
|
|
2022-04-06 |
2022-04-04 |
PlS
Planned sale
|
EVP/Pres, Health Care Benefits
Officer
|
12,032
-24.0%
100.13
US$1,204,764
|
12,032
-24.0%
|
100.13
|
US$1,204,764
|
|
|
2022-04-06 |
2022-04-04 |
PlS
Planned sale
|
EVP/Pres, Health Care Benefits
Officer
|
27,166
-35.1%
100.13
US$2,720,132
|
27,166
-35.1%
|
100.13
|
US$2,720,132
|
|
|
2022-04-06 |
2022-04-04 |
PlS
Planned sale
|
EVP/Pres, Health Care Benefits
Officer
|
16,161
-24.4%
100.13
US$1,618,201
|
16,161
-24.4%
|
100.13
|
US$1,618,201
|
|
|
2022-03-18 |
2022-03-17 |
S
Sale
|
EVP and Co-President of Retail
Officer
|
2,935
-4.7%
106.65
US$313,018
|
2,935
-4.7%
|
106.65
|
US$313,018
|
|
|
2022-03-18 |
2022-03-17 |
S
Sale
|
EVP and Co-President of Retail
Officer
|
1,689
-2.8%
106.65
US$180,132
|
1,689
-2.8%
|
106.65
|
US$180,132
|
|
|
2022-03-17 |
2022-03-15 |
S
Sale
|
EVP & General Counsel
Officer
|
51,361
-5.8%
105.00
US$5,392,905
|
51,361
-5.8%
|
105.00
|
US$5,392,905
|
|
|
2022-02-11 |
2022-02-10 |
B
Purchase
|
Non-Executive Director
|
1,000
+5.8%
105.90
US$105,904
|
1,000
+5.8%
|
105.90
|
US$105,904
|
|
|
2022-02-04 |
2022-02-03 |
PlS
Planned sale
|
EVP and Chief Medical Officer
Officer
|
47,937
-25.7%
110.00
US$5,273,070
|
47,937
-25.7%
|
110.00
|
US$5,273,070
|
|
|
2022-02-02 |
2022-02-01 |
PlS
Planned sale
|
EVP&President-PharmacyServices
Officer
|
21,386
-25.9%
106.50
US$2,277,566
|
21,386
-25.9%
|
106.50
|
US$2,277,566
|
|
|
2022-02-01 |
2022-01-28 |
PlS
Planned sale
|
SVP, Cont & Chief Acct Officer
Officer
|
6,059
-25.7%
109.00
US$660,431
|
6,059
-25.7%
|
109.00
|
US$660,431
|
|
|
2022-01-28 |
2022-01-27 |
PlS
Planned sale
|
EVP & Chief Operating Officer
Officer
|
68,482
-39.0%
107.50
US$7,361,815
|
68,482
-39.0%
|
107.50
|
US$7,361,815
|
|
|
2021-11-05 |
2021-11-03 |
PlS
Planned sale
|
EVP & Chief Operating Officer
Officer
|
108,870
-50.4%
95.00
US$10,342,650
|
108,870
-50.4%
|
95.00
|
US$10,342,650
|
|
|
2021-11-03 |
2021-11-01 |
S
Sale
|
EVP and Chief Medical Officer
Officer
|
28,159
-16.9%
90.00
US$2,534,310
|
28,159
-16.9%
|
90.00
|
US$2,534,310
|
|
|
2021-10-28 |
2021-10-26 |
PlS
Planned sale
|
EVP and Chief Medical Officer
Officer
|
80,802
-36.9%
88.00
US$7,110,576
|
80,802
-36.9%
|
88.00
|
US$7,110,576
|
|
|
2021-10-28 |
2021-10-26 |
S
Sale
|
EVP and Chief Medical Officer
Officer
|
1,955
-0.9%
88.00
US$172,040
|
1,955
-0.9%
|
88.00
|
US$172,040
|
|
|
2021-06-29 |
2021-06-28 |
PlS
Planned sale
|
EVP&President-PharmacyServices
Officer
|
2,781
-4.4%
83.67
US$232,686
|
2,781
-4.4%
|
83.67
|
US$232,686
|
|
|
2021-06-17 |
2021-06-15 |
PlS
Planned sale
|
EVP and Chief Medical Officer
Officer
|
67,552
-32.1%
86.00
US$5,809,472
|
67,552
-32.1%
|
86.00
|
US$5,809,472
|
|
|
2021-06-08 |
2021-06-07 |
PlS
Planned sale
|
EVP/Pres, Health Care Benefits
Officer
|
37,594
-61.7%
86.60
US$3,255,640
|
37,594
-61.7%
|
86.60
|
US$3,255,640
|
|
|
2021-05-12 |
2021-05-10 |
PlS
Planned sale
|
EVP & General Counsel
Officer
|
109,469
-100.0%
86.00
US$9,414,334
|
109,469
-100.0%
|
86.00
|
US$9,414,334
|
|
|
2021-05-10 |
2021-05-07 |
PlS
Planned sale
|
EVP and Chief Medical Officer
Officer
|
9,477
-6.1%
84.00
US$796,068
|
9,477
-6.1%
|
84.00
|
US$796,068
|
|
|
2021-05-06 |
2021-05-04 |
PlS
Planned sale
|
EVP & CFO
Officer
|
4,905
-4.1%
80.00
US$392,400
|
4,905
-4.1%
|
80.00
|
US$392,400
|
|
|
2021-04-23 |
2021-04-21 |
PlS
Planned sale
|
EVP & General Counsel
Officer
|
2,420
-100.0%
77.00
US$186,340
|
2,420
-100.0%
|
77.00
|
US$186,340
|
|
|
2021-04-23 |
2021-04-21 |
PlS
Planned sale
|
EVP & General Counsel
Officer
|
101,003
-97.7%
77.00
US$7,777,231
|
101,003
-97.7%
|
77.00
|
US$7,777,231
|
|
|
2021-04-01 |
2021-03-31 |
PlS
Planned sale
|
SVP, Cont & Chief Acct Officer
Officer
|
5,350
-42.5%
76.00
US$406,600
|
5,350
-42.5%
|
76.00
|
US$406,600
|
|
|
2021-03-30 |
2021-03-29 |
PlS
Planned sale
|
EVP & General Counsel
Officer
|
62,943
-100.0%
76.15
US$4,793,109
|
62,943
-100.0%
|
76.15
|
US$4,793,109
|
|
|
2021-03-29 |
2021-03-26 |
PlS
Planned sale
|
Non-Executive Director
|
270,650
-34.1%
74.73
US$20,225,674
|
270,650
-34.1%
|
74.73
|
US$20,225,674
|
|
